文献速递临床试验与 GCP真实世界研究与卫生经济

PRO-P:评估电子患者报告结局指标监测与标准护理对接受手术的前列腺癌患者的效果——一项随机对照试验的研究方案

PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2024-11-12

PRO-P是一项在6个中心开展的随机对照试验,计划纳入260例术后6周存在尿失禁(≥1片尿垫/天)的前列腺癌根治术患者,1:1随机分组,比较基于EPIC-26等领域的ePROM监测触发预警与标准护理。主要终点为尿控,次要终点包括EPIC-26各领域、心理困扰和生活质量,并进行质性过程评价。

要点

  • 术后6周尿失禁≥1片/天的前列腺癌根治术患者260例,1:1随机分组。
  • ePROM监测超过预设PRO评分阈值时触发中心预警,进而联系患者并给予医疗咨询和可能的干预。
  • 主要终点为尿控,次要终点为EPIC-26各领域、心理困扰和生活质量。

核心结论

  • PRO-P研究ePROM结构化随访在前列腺癌根治术后第一年对术后症状监测的效果,是首批探讨PRO监测及其在常规护理中可能适用性的癌症手术研究之一。
  • PRO-P可能通过结构化使用ePROM改善前列腺癌根治术患者的尿失禁和生活质量。

研究设计与样本

  • 随机对照试验,术后6周按1:1随机分组,纳入260例术后6周存在尿失禁(≥1片尿垫/天)的患者,涉及6个参与中心。
  • 计划招募1年,随后随访1年。
  • 在术后6、12、18、24、36和52周评估基于EPIC-26领域、心理负担和生活质量的PRO监测。
  • 在质性过程评价框架内探讨该干预的可行性、效果和实施方面。

主要发现

  • 超过预设PRO评分阈值会触发中心预警,促使联系患者、医疗咨询和可能的干预。
  • 主要终点为尿控,次要终点涉及EPIC-26领域、心理困扰和生活质量。
  • 通过将信息技术适配德国癌症协会认证标准并通过联合患者门户整合ePROM调查,促进该干预在临床实践中的潜在适用性。

临床怎么用

  • 作者认为,阳性结果可便于将这一复杂干预转化为常规临床护理。
  • 作者认为,PRO-P可能通过结构化使用ePROM改善前列腺癌根治术患者的尿失禁和生活质量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With over 65,000 new cases per year in Germany, prostate cancer (PC) is the most common cancer in men in Germany. Localized PC is often treated by radical prostatectomy and has a very good prognosis. Postoperative quality of life (QoL) is significantly influenced by the side effects of surgery. One possible approach to improve QoL is postoperative symptom monitoring using ePROMs (electronic patient-reported outcome measures) to accurately identify any need for support. METHODS: The PRO-P ("Influence of ePROMS in surgical therapy of PC on the postoperative course") study is a randomized controlled trial employing 1:1 randomization at 6 weeks postoperatively, involving 260 patients with incontinence (≥ 1 pad/day) at six participating centers. Recruitment is planned for 1 year with subsequent 1-year follow-up. PRO-monitoring using domains of EPIC-26, psychological burden, and QoL are assessed 6, 12, 18, 24, 36, and 52 weeks postoperatively. Exceeding predefined PRO-score cutoffs triggers an alert at the center, prompting patient contact, medical consultation, and potential interventions. The primary endpoint is urinary continence. Secondary endpoints refer to EPIC-26 domains, psychological distress, and QoL. Aspects of feasibility, effect, and implementation of the intervention will be investigated within the framework of a qualitative process evaluation. DISCUSSION: PRO-P investigates the effect on postoperative symptom monitoring of a structured follow-up using ePROMs in the first year after prostatectomy. It is one of the first studies in cancer surgery investigating PRO-monitoring and its putative applicability to routine care. Patient experiences with intensified monitoring of postoperative symptoms and reflective counseling will be examined in order to improve primarily urinary continence, and secondly other burdens of physical and psychological symptoms, quality-of-life, and patient competence. The potential applicability of the intervention in clinical practice is facilitated by IT adaption to the certification standards of the German Cancer Society and the integration of the ePROMs survey via a joint patient portal. Positive outcomes could readily translate this complex intervention into routine clinical care. PRO-P might improve urinary incontinence and QoL in patients with radical prostatectomy through the structured use of ePROMs. TRIAL REGISTRATION: ClinicalTrials.gov NCT05644821. Registered on 09 December 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Al-Monajjed R, Albers P, Droop J, et al. PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial. Trials. 2024. PMID: 39533412. doi:10.1186/s13063-024-08579-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。